TG Therapeutics is a fully integrated, commercial stage, biotechnology company focused on the acquisition, development and commercialization of novel treatments for B-cell diseases. In addition to a research pipeline, TG Therapeutics has received approval from the U.S. Food and Drug Administration (FDA) for BRIUMVI® (ublituximab-xiiy) to treat adult patients with relapsing forms of multiple sclerosis, including clinically isolated syndrome, relapsing-remitting disease, and active secondary progressive disease, as well as approval from several regulatory agencies outside of the U.S. for BRIUMVI to treat adult patients with RMS who have active disease defined by clinical or imaging features. read more

EMPLOYEE PARTICIPANTS: 19

TOTAL RATINGS: 339

CEO: Michael S. Weiss

HR or Marketing? Claim Your Free Employer Account

TG Therapeutics Executive Team

The TG Therapeutics Executive Team is rated a "C+" and led by CEO Michael S. Weiss. TG Therapeutics employees rate their Executive Team in the Top 50% of similar size companies on Comparably with 201-500 Employees.

Employees with 3 to 6 Years experience and Female employees are more confident in their Executive Team, while employees with 1 to 3 Years experience and Male employees think there is room for improvement. Out of their 3 competitors, Biogen, MyoKardia, and Reata Pharmaceuticals, TG Therapeutics' score ranks in 2nd place.

Last updated 11 days ago.

Where This Score Ranks TG Therapeutics' Executive Team

TOP
50%
In the Top 50% of 1623 Similar Sized Companies on Comparably
2nd
2nd place versus 3 competitors rated on Comparably

Jul

Aug

Jun

Aug

Apr

C+66 / 100

May

TG Therapeutics Key Executives

Name & Title

Bio

Who Ranks TG Therapeutics' Executive Team the Highest?

Experience - 3 to 6 Years 77/100

Gender - Female 67/100

Ethnicity - Hispanic or Latino 64/100

Who Ranks TG Therapeutics' Executive Team the Lowest?

Experience - 1 to 3 Years 40/100

Gender - Male 42/100

Ethnicity - Caucasian 60/100

TG Therapeutics' Executive Team Trendline

TG Therapeutics66
Similar Size on Comparably

TG Therapeutics Executive Team At a Glance

The Executive Team Score of 66/100 is calculated by combining aggregate responses to the questions of “How would you rate your executive team?” and “Do you approve of the job your executive team is doing at your company?”

33% of employees say “Yes, they approve of the job the executive team is doing at TG Therapeutics.”

The last rating scoring TG Therapeutics' executive team was provided 11 days ago and has remained stable at 66 over the last 90 days.

How TG Therapeutics' Executive Team Score is Calculated

out of 100

How would you rate your executive team?

Answer	Percent
Yes	33%
No	67%

Do you approve of the job your executive team is doing at your company?

TG Therapeutics' Executive Team Rank Against Similar Sized Companies on Comparably

TOP

50%

TG Therapeutics ranks in the Top 50% of other companies on Comparably with 201-500 Employees for Executive Team Score.

Anonymously Ask TG Therapeutics Any Question

Are You an Employee at TG Therapeutics?

Anonymously Rate Your Experience & Make Work Better

See other culture dimensions at TG Therapeutics

Rate your company